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Received May 7, 2012; accepted June 13, 2012AbstractBackground: Diabetes mellitus management is one of the most challenging health care issues in Taiwan. To improve guideline adherence and the
quality of diabetes care, the diabetes mellitus pay-for-performance (DM-P4P) program was introduced in 2001. This study examined the effects
of the DM-P4P program on guideline adherence among patients with diabetes.
Methods: This cross-sectional study used National Health Insurance (NHI) claim data to assess guideline adherence among three groups of
patients with diabetes: patients enrolled in the DM-P4P program, patients not enrolled but treated by DM-P4P-participating physicians, and
patients treated by non-P4P physicians. Guideline adherence measures included hemoglobin A1c, blood glucose, lipid, serum creatinine, alanine
transaminase, urinalysis, and eye examinations. Multiple logistic regression with generalized estimated equation approach were used to assess
the effect of the DM-P4P program while controlling for patient and physician characteristics.
Results: A total of 520,804 patients were included in the analysis. Patients enrolled in the DM-P4P program were more likely to receive all of the
guideline-recommended tests/examinations than patients treated by non-P4P physicians. Patients who were not enrolled in the program but who
were treated by DM-P4P-participating physicians were more likely to receive three of the seven recommended tests/examinations than were
those treated by non-P4P physicians.
Conclusion: When physicians participated in the P4P program, this increased the likelihood that patients would receive guideline-recommended
tests or examinations. Increasing the DM-P4P participation rates for physicians and patients are important and worthwhile objectives that can
assist in the effort to more effectively manage diabetes in the general population.
Copyright  2012 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Clinical guidelines are recommended by healthcare
professionals to increase the effectiveness both of patient
diagnosis and treatment.1 Pay-for-performance (P4P)
programs, which provide financial rewards for healthcare
providers to increase adherence to care guidelines, have
become a major policy priority in many countries.2e4 Despite
the increased use of P4P designated programs, the results of* Corresponding author. Dr. Ying-Hui Hou, Department of Health Industry
Management, School of Healthcare Management, Kainan University, 1 Kainan
Road, Room B959, Taoyuan 338, Taiwan, ROC.
E-mail address: yhhou@mail.knu.edu.tw (Y.-H. Hou).
1726-4901/$ - see front matter Copyright  2012 Elsevier Taiwan LLC and the C
http://dx.doi.org/10.1016/j.jcma.2012.06.024previous studies evaluating the effect of P4P on guideline
adherence have been inconclusive. Some studies5e8 found that
patients treated by P4P-participating physicians were more
likely to receive quality care than patients who were not
treated by P4P physicians, whereas other studies9,10 found
a modest effect or no effect. It would appear that more
research is needed to verify the effectiveness of P4P programs.
Diabetes mellitus (DM) management is one of the most
challenging healthcare issues in Taiwan. There are 1.51
million patients with diabetes,11 and the prevalence of diabetes
in people age 19 years and older is 9.05%.12 In addition,
diabetes has been ranked as the fifth leading cause of death
since 1987. Previous studies have reported that diabetes
management and quality of care are less than optimal.13,14hinese Medical Association. All rights reserved.
103C.-L. Lai, Y.-H. Hou / Journal of the Chinese Medical Association 76 (2013) 102e107This may be due in part to poor provider adherence to practice
guidelines and significant variation among physician special-
ties, which are commonplace in Taiwan.15e17 In 2001, the
Bureau of National Health Insurance (NHI) introduced a P4P
program for DM, which aimed to improve guideline adherence
and quality of diabetes care among clinical practitioners.
Physicians who have completed continuing medical
education (CME) and receive a “Diabetes Shared Care
Program” (DSCP) certificate from the local health authority
are eligible to participate in the DM-P4P program. The
program offers financial incentives to P4P-participating
physicians to enroll their patients with Type 1 or Type 2 dia-
betes in the DM-P4P program. An additional administration
fee, DM education fee, and comprehensive follow-up
consultation fee are included in the P4P program for physi-
cians’ compensation. Guideline-recommended tests and
examinations are process indicators used to monitor the
comprehensiveness of follow-up visits. Later, outcome-based
indicators, such as hemoglobin A1c and low-density lipopro-
tein levels, are included as barometers to measure improve-
ment in the incentive program.
Participation in the DM-P4P program is voluntary for
physicians; in addition, the physician has the ability to select
patients to be enrolled in the P4P program. Evidence shows
that patients enrolled in the P4P program have an increased
likelihood of receiving guideline-recommended tests and
examinations compared with patients who are not
enrolled,18e21 but patients with more severe conditions asso-
ciated with DM are more likely to be excluded from enroll-
ment.20,22 Because the program is a physician-level incentive
strategy to improve care quality, profiling and comparing the
quality of care provided by different physician groups is
a valuable strategy for quality improvement.23 However, there
are few studies exploring the association between guideline
adherence and participation in the DM-P4P program at the
physician level.
The primary goal of this study is to examine the effect of
the DM-P4P program on guideline adherence among patients
with diabetes according to physician participation status. We
hypothesize that patients enrolled in the DM-P4P program will
receive the most comprehensive laboratory tests and physical
examinations as recommended by the guidelines; patients who
are not enrolled but are treated by P4P-participating physi-
cians will receive less comprehensive tests/examinations, and
those treated by nonparticipating physicians (i.e., cannot be
enrolled in the program) will receive the least comprehensive
tests/examinations.
2. Methods
The data for this study came from an NHI claim dataset that
was obtained from the National Health Research Institute. The
dataset included the registry for medical personnel, board-
certified specialists, contracted medical facilities, and ambu-
latory and inpatient care records. We used a cross-sectional
comparison design to investigate the effect of the DM-P4P
program on patients in various physician groups. Patientswith diabetes were defined as having received a primary
diagnosis of diabetes (International Classification of Diseases,
Ninth Revision, Clinical Modification [ICD-9-CM] codes 250)
on two outpatient visits. Because a patient might visit more
than one doctor for diabetes care, the physician she/he visited
most frequently for diabetes care was assigned as the “prin-
cipal provider” for that patient.24 Physicians who had treated
at least 50 patients with DM in 2008 were included. Physicians
who were generalists, or who did not specialize in internal
medicine, endocrinology, family medicine, or pediatrics were
excluded, which enabled the study to represent the primary
care providers of diabetes care.
Therefore, two groups of physicians were identified: the
P4P-participating physicians who participated in the DM-P4P
program in 2008 (n¼ 908), and those who did not participate
in the P4P program (n¼ 1770). We further divided the patients
treated by P4P-participating physicians into two groups: the
enrollee group, consisting of patients who had been enrolled in
the program in 2008 (n¼ 146,467), and the potential enrollee
group, consisting of patients who were not enrolled in the
program (n¼ 197,145). Because the DSCP certifies physicians
for 3 years, physicians could be in or out of the program at any
time during the study period. The comparison group consisted
of physicians who had not joined the DM-P4P program
between 2006 and 2008 (n¼ 1627) and their patients
(n¼ 177,192). This study is exempt from human subjects
review because it used existing, publicly available data
collected and compiled by Taiwan’s government agencies, and
does not include information that could directly or indirectly
identify the subjects of this investigation.
Adherence to the guideline measures was the main
response variable in this study. The guideline measures sug-
gested by the DM-P4P program included the following seven
items: hemoglobin A1c measurement (HbA1c), fasting and
postprandial glucose checkup (glucose), lipid profile (lipid),
serum creatinine (sCr), alanine transaminase (ALT), urine
routine or urine microalbumin (urinalysis), and eyeground
examination or ophthalmic photograph (eye). Lipid measure-
ments included serum total cholesterol, fasting serum
triglycerides, high-density lipoprotein cholesterol, and low-
density lipoprotein cholesterol. For each patient, we
recorded any claim for any of the measures derived from
ambulatory and inpatient care records in 2008. A patient who
had tests/examinations of the item more than once was
considered to have adherence to this measure.
The independent variables used were dichotomous indica-
tors for whether patients were in the enrollee or potential
enrollee groups, using those who were treated by nonpartici-
pating physicians as the comparison group. The covariates
included physician sex, age, specialty, practice setting
(academic medical center, regional hospital, community
hospital, or clinic), number of diabetes patients, institution
ownership, and urbanization of institution and patient sex, age,
DM treatment (diet-controlled, oral medication only, or
treatment with insulin), diabetes complication severity index
(DCSI score),25 and the number of diabetes-related physician
visits. The DCSI contains seven categories of complications,
Table 1
Characteristics of physicians in P4P-physician group and comparison group.
Characteristic P4P-physician
group
n (%) or
mean  SD
Comparison
group
n (%) or
mean  SD
Participation
rate, %
pa
No. of physicians 908 1,627 35.8
Sex <0.001
Female 145 (16.0) 113 (7.0) 56.2
Male 763 (84.0) 1,514 (93.0) 33.5
Age (y) <0.001
<35 83 (9.1) 79 (4.9) 51.2
35e49 509 (56.1) 909 (55.9) 35.9
50e65 300 (33.0) 586 (36.0) 33.9
>65 16 (1.8) 53 (3.2) 23.2
Mean 46.7  8.7 47.8  8.3
Specialty <0.001
Internal medicine 553 (60.9) 991 (60.9) 35.8
Family practice 232 (25.6) 521 (32.0) 30.8
Endocrinology 80 (8.8) 5 (0.3) 94.1
Pediatrics 23 (2.5) 34 (2.1) 40.4
General practice 20 (2.2) 76 (4.7) 20.8
Practice setting <0.001
Academic medical
center
118 (13.0) 222 (13.6) 34.7
Regional hospital 240 (26.4) 221 (13.6) 52.1
Community hospital 173 (19.1) 265 (16.3) 35.9
Clinic 377 (41.5) 919 (56.5) 29.1
Diabetes patients <0.001
50e79 136 (15.0) 788 (48.4) 14.7
80e179 287 (31.6) 690 (42.4) 29.4
180 485 (53.4) 149 (9.2) 76.5
Mean 378  430 109  111
Ownership <0.001
Public 272 (30.0) 294 (18.1) 48.1
Private 636 (70.0) 1,333 (81.9) 32.3
Location <0.001
Urban 568 (62.6) 897 (55.1) 38.8
Suburban 277 (30.5) 539 (33.1) 33.9
Rural 63 (6.9) 191 (11.8) 24.8
SD¼ standard deviation.
a The statistical significance was calculated by the c2 test.
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tion, and assigns a score to each category (ranging from 0 to
2). This score was calculated annually for each patient based
on all primary and secondary diagnostic codes for all of the
patients’ ambulatory and inpatient visits in that year; higher
scores indicate higher levels of severity. The number of dia-
betes visits represents the frequency of diabetes-related (ICD-
9-CM codes 250) ambulatory appointments for each patient in
2008.
Descriptive statistics were calculated for all of the variables
for participant and comparison groups and are presented as
a percentage or the mean  standard deviation (SD). The c2
test and t test were used to examine the between-group
differences in categorical and continuous variables, respec-
tively. For each guideline measure, multiple logistic regression
models were constructed to calculate estimated odds ratios and
95% confidence intervals comparing the enrollee versus
comparison groups and the potential enrollee versus compar-
ison groups. Logistic regression models were fit using the
generalized estimating equation (GEE) approach to account
for the likely nonindependence among patients treated by the
same physician and within the same hospital or clinic. Odds
ratios were estimated from GEE logistic regression models,
and adjusted for patient and physician characteristics. We
further converted the odds ratios to risk ratios because odds
ratios may not be the optimal metric when rates are high.26,27
SAS software version 9.2 (SAS Institute Inc., Cary, NC, USA)
was used for the data and statistical analyses.
3. Results
Physician characteristics according to DM-P4P participa-
tion status are shown in Table 1. Approximately 36% of the
physicians participated in the DM-P4P program. Physicians in
the P4P physician group were more likely to be female,
younger, and included a greater percentage of specialists in
endocrinology, whereas comparison group physicians were
more likely to practice in clinics, private hospitals, and rural
areas. Physicians who participated in the P4P program had
a higher average number of patients with diabetes than
nonparticipants (378 versus 109), and 53% had more than 180
patients with DM.
A total of 520,804 patients were analyzed (Table 2),
including 146,467 in the enrollee group (who were treated by
P4P physicians), 197,145 in the potential enrollee group (who
were not enrolled but treated by P4P physicians), and 177,192
in the comparison group (who were treated by nonpartici-
pating physicians). Patients in the enrollee group were more
likely to be female, older, and have a higher number of
diabetes-related visits, whereas those in the potential enrollee
group were more likely to be treated with insulin and have
a higher DCSI score. Patients in the comparison group were
more likely to be older, treated with oral medication, have
a lower DCSI score, and have fewer diabetes-related visits
than those in the enrollee or potential enrollee groups.
For all seven tests and examinations, patients in the enrollee
group were more likely to receive these tests/examinationsthan those in the comparison group; these figures were also
higher in the potential enrollee group than in the comparison
group (Table 3). Statistically significant differences were
observed between the enrollee group and the comparison
group for HbA1c (100% vs. 85%) glucose testing (100% vs.
96%), lipid profile (80% vs. 28%), sCr (93% vs. 74%), ALT
(91% vs. 65%), urinalysis (77% vs. 24%), and eye examina-
tion (67% vs. 19%). Similarly, statistically significant differ-
ences were observed between the potential enrollee group and
comparison group, with the potential enrollee group having
a higher adherence rate to HbA1c (92% vs. 85%), glucose
testing (98% vs. 96%), lipid profile (41% vs. 28%), sCr (85%
vs. 74%), ALT (79% vs. 65%), urinalysis (38% vs.9%), and
eye examination (27% vs. 19%).
The results of the regression models, controlled for both
patient and physician characteristics, are shown in Table 4.
Patients in the enrollee group were significantly more likely to
receive each of the seven guideline-recommended measures
compared with patients in the comparison group. Patients in
Table 2
Characteristics of patients by enrollee, potential enrollee, and comparison
group.
Characteristic P4P-physician groupa
n (%) or mean  SD
Comparison groupa
n (%) or
mean  SD
Enrollee Potential enrollee
No. of patients 146,467 197,145 177,192
Sex
Female 76,397 (52.2) 96,729 (49.1) 90,281 (50.9)
Male 70,070 (47.8) 100,416 (50.9) 86,991 (49.1)
Age (y)
<45 11,973 (8.2) 20,545 (10.4) 13,695 (7.7)
45e64 71,413 (48.7) 91,555 (46.4) 84,533 (47.7)
65 63,081 (43.1) 85,045 (43.2) 78,964 (44.6)
Mean 61.6  12.5 61.5  13.8 62.2  12.7
Treatment of DM
Diet controlled 2,100 (1.4) 8,925 (4.5) 7,431 (4.2)
Oral medication 113,148 (77.3) 142,018 (72.0) 147,842 (83.4)
Insulin 31,219 (21.3) 46,202 (23.5) 21,919 (12.4)
DCSI score
0 59,804 (40.8) 86,209 (43.7) 86,063 (48.6)
1 41,717 (28.5) 48,765 (24.7) 42,168 (23.8)
2 20,640 (14.1) 25,112 (12.8) 20,389 (11.5)
3 24,306 (16.6) 37,059 (18.8) 28,572 (16.1)
Mean 1.24  1.56 1.31  1.72 1.16  1.65
No. of diabetes visits 14.7  7.7 14.5  8.5 12.9  7.6
DCSI¼Diabetes Complications Severity Index; DM¼ diabetes mellitus.
a There were significant differences ( p< 0.001) in all variables of patients’
characteristics among enrollee, potential enrollee, and comparison groups. The
statistical difference was calculated by the c2 test for categorical variables and
by the t test for continuous variables.
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receive three of the seven recommended tests/examinations
(lipid, ALT, and eye examination) than patients in the
comparison group.
4. Discussion
This study compared the degree of guideline adherence
between DM-P4P-participating physicians and non-P4P
physicians by examining the recommended tests or examina-
tions received by their patients. The results supported our
hypotheses that DM-P4P enrollees would receive the most
comprehensive guideline-recommended tests/examinations,Table 3
Rates of patients receiving guideline recommended test/examinations in the enroll
Measure Enrollee, % Potential
enrollee, %
HbA1c 100 92
Glucose 100 98
Lipid 80 41
sCr 93 85
ALT 91 79
Urinalysis 77 38
Eye 67 27
xp< 0.1; *p< 0.05; yp< 0.01; zp< 0.001.
ALT¼alanine transaminase; Hb¼ hemoglobin; sCr¼ serum creatinine.
a The difference and statistical significance were calculated by the t test.that patients who were not enrolled but were treated by P4P-
participating physicians would receive less comprehensive
tests/examinations, and that patients treated by nonpartici-
pating physicians would receive the least comprehensive tests/
examinations. Our findings suggest that the DM-P4P program,
through CME and reimbursement incentives to the partici-
pating physicians, significantly increased the provision of
guideline-recommended tests or examinations to their patients.
These results are similar to those of certain previous
studies.5e8
Not surprisingly, patients enrolled in the DM-P4P program
are more likely to receive all of the guideline-recommended
laboratory tests and examinations than are nonenrollees;
similar results have been reported by other groups.18e21
Moreover, these findings also show that patients who were
not enrolled in the P4P program but were treated by DM-P4P-
participating physicians were more likely to receive three of
the seven tests/examinations than those treated by non-P4P
physicians. Because these patients were not enrolled in the
P4P program, there was no financial incentive for the physi-
cian to provide comprehensive care, including recommended
tests and examinations.
The better performance of DM-P4P-participating physi-
cians in providing guideline-recommended care might be due
to increased awareness through CME or the physician’s
established practice pattern. CME is an effective way to
enhance professional practice28; therefore, the participating
physicians might be aware of current guidelines, and thus are
more likely to follow the guideline recommendations.
However, some studies have indicated that physicians who
already followed clinical guidelines or were more receptive to
the P4P program were more likely to participate in the
program.5,6,10 Regardless of the explanations for the physi-
cians’ differential performance, it is clear that patients treated
by nonparticipating physicians receive the least comprehen-
sive care. Increasing the DM-P4P participation rate of the
physicians or encouraging patients with DM to be treated by
P4P-participating physicians could prove to be valuable policy
options for health authorities. Further studies may investigate
and analyze the factors associated with physician participation
in the program, or possibly the attitudes and concerns of
nonparticipating physicians, both intended to provide moreee, potential enrollee, and comparison groups.
Comparison
group, %
Difference, % (95 CI)a
Enrollee vs.
comparison
Potential enrollee
vs. comparison
85 15 (14.8, 15.1)z 7 (7.4, 7.8)z
96 4 (3.5, 3.7)z 2 (1.9, 2.1)z
28 52 (51.9, 52.5)z 13 (12.3, 12.9)z
74 19 (18.6, 19.1)z 11 (10.8, 11.3)z
65 26 (25.9, 26.4)z 13 (13.1, 13.6)z
24 53 (52.9, 53.5)z 14 (13.8, 14.4)z
19 48 (38.0, 48.6)z 9 (8.4, 9.0.)z
Table 4
Results from multiple logistic regression models with generalized estimated
equation approach for the seven recommended tests/examinations.
Measure Adjusted risk ratio (95% confidence interval)a
Enrollee vs.
comparison
Potential enrollee
vs. comparison
HbA1c 1.17 (1.17, 1.18)d 1.00 (0.97,1.03)
Glucose 1.04 (1.04, 1.04)d 1.01 (1.00,1.01)
Lipid 2.85 (2.72, 2.97)d 1.24 (1.04, 1.45)c
sCr 1.20 (1.18, 1.23)d 0.97 (0.93,1.01)
ALT 1.37 (1.34, 1.39)d 1.06 (1.00, 1.11)b
Urinalysis 3.04 (2.82, 3.24)d 1.15 (0.93,1.38)
Eye 3.41 (3.25, 3.56)d 1.21 (1.11, 1.31)d
bp< 0.1. cp< 0.05. dp< 0.001.
ALT¼alanine transaminase; Hb¼ hemoglobin; sCr¼ serum creatinine.
a The risk ratio and statistical significance were calculated by generalized
estimating equation logistic regression models.
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participation.
The results also highlighted several potential risks of
patient selection and treatment disparity in the patients treated
by DM-P4P-participating physicians. Less than half (43%) of
the patients treated by DM-P4P-participating physicians had
been enrolled in the P4P program. Patients with more severe
complications (e.g., higher DCSI score) or insulin dependency
were more likely to be excluded from joining the program.
This finding is consistent with previous studies of the DM-P4P
program.20,22 It is possible that patients with more comor-
bidities or insulin prescriptions require greater applied efforts
to achieve treatment targets,29,30 which is important in
a system where the physicians have full discretion to enroll
patients into the program. In addition, the inability to reconcile
patient preferences with guideline recommendations is
a barrier to physician adherence to guidelines.31 Because the
DM-P4P program requires that all program enrollees receive
a comprehensive education program, hard-to-manage patients
are more likely to be excluded.
However, the problem of patient selection may also indicate
a possible deficiency of the reimbursement program, which
may require remediation. Several approaches have been
proposed to address this challenge, including mandated
participation, risk-adjustment of quality indicators, setting
maximum achievement thresholds below 100%, and excluding
specific patients from the index calculations.22,32 In addition,
further analysis of the factors associated with low provision
rates of specific tests/examinations, such as lipid tests,
urinalysis, and eye examination, for nonenrolled patients
might provide more information about noncompliance.
It should be noted that this study has several limitations.
The study excluded physicians with fewer than 50 patients
with DM, which is the mandated threshold of financial reward
for the achievement of patient outcomes. Consequently, the
results are not representative of low-volume physicians. The
lack of information on patient socioeconomic status and
education might bias our findings; previous reports have
revealed that these variables are associated with patient
adherence to medical advice.33,34In conclusion, physicians participating in the DM-P4P
program provided significantly more guideline-recommended
tests and examinations to their patients. Furthermore,
patients who were treated by nonparticipating physicians
received less comprehensive care than patients treated by P4P-
participating physicians. Due to the high prevalence of dia-
betes in Taiwan, any and all efforts to increase DM-P4P
participation rates for physicians and patients are both
worthwhile and necessary.
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